Dose-dependent systolic contribution of differentiated stem cells in post-infarct ventricular function

Area of Science:

• Cardiovascular Research
• Regenerative Medicine
• Stem Cell Therapy

Background:

• Cardiac cell therapy aims to restore heart function post-myocardial infarction.
• Optimal cell types and mechanisms for functional improvement remain unclear.
• This study investigated dose-dependent effects of cardiomyocyte-like cells (CLCs) and mesenchymal stem cells (MSCs).

Purpose of the Study:

• To compare the efficacy of CLCs and MSCs in improving cardiac function after myocardial infarction.
• To determine if cell transplantation has a dose-dependent effect on functional recovery.
• To elucidate the mechanisms underlying functional improvement mediated by CLCs and MSCs.

Main Methods:

• Wistar rats underwent myocardial infarction and received peri-infarct injections of MSCs or CLCs at two different doses (1x10^6 or 5x10^6 cells).
• Cardiac function was assessed 6 weeks post-transplantation.
• Load-independent measurements were used to evaluate systolic and diastolic function.

Main Results:

• High-dose CLCs significantly improved cardiac contractility compared to MSCs, demonstrating a dose-response effect.
• CLCs showed superiority in load-independent systolic measurements, indicating a unique role in contractility recovery.
• MSCs primarily preserved endogenous myocyte function and limited chamber dilation via angiogenesis.

Conclusions:

• Committing stem cells to a cardiac phenotype ex vivo enhances their integration and functional recovery in infarcted myocardium.
• CLCs demonstrated superior mechanical and functional integration compared to MSCs.
• Cell type-specific effects highlight the importance of ex vivo differentiation for effective cardiac cell therapy.